tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $7.11. This is a potential upside of $4.46 (168.3%) from yesterday's end of day stock price of $2.65.
Kinnate Biopharma 's activity chart (see below) currently has 31 price targets and 32 ratings on display.
Analysts average stock forecasts to be materialized ratio is 8.84% with an average time for these price targets to be met of 16.86 days.
Most recent stock forecast was given by BENJAMIN BURNETT from STIFEL on 26-Feb-2024.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$2.59
$5.4
1 years 7 months 24 days ago
(26-Feb-2024)
1/7 (14.29%)
$0.14 (5.71%)
4
Hold
$2
$-0.65 (-24.53%)
$2
1 years 9 months 2 days ago
(17-Jan-2024)
1/7 (14.29%)
$-0.36 (-15.25%)
57
Hold
$4
$1.35 (50.94%)
2 years 1 months ago
(19-Sep-2023)
0/5 (0%)
$2.5 (166.67%)
Buy
$2
$-0.65 (-24.53%)
2 years 1 months ago
(19-Sep-2023)
1/3 (33.33%)
$0.5 (33.33%)
57
Hold
2 years 1 months ago
(19-Sep-2023)
0/1 (0%)
$21.33 (182.78%)
What is KNTE (Kinnate Biopharma ) average time for price targets to be met?
Which analyst has the current highest performing score on KNTE (Kinnate Biopharma ) with a proven track record?
Which analyst has the current lower performing score on KNTE (Kinnate Biopharma ) with a proven track record?
Which analyst has the most public recommendations on KNTE (Kinnate Biopharma )?
Which analyst is the currently most bullish on KNTE (Kinnate Biopharma )?
Which analyst is the currently most reserved on KNTE (Kinnate Biopharma )?
